Patent · US Active

Method of treating idiopathic pulmonary fibrosis by administering human oncostatin M antibodies

US10179812B2 · kind B2 · utility

0Cited by

23References

4Claims

0Family size

Inventors

Juan Carlos Almagro · Brookline, US
William DuBell · Jamison, US
Johann Fransson · San Diego, US
Jose Pardinas · Spring House, US
Gopalan Raghunathan · San Diego, US

Key dates

Filing date	Feb 2, 2017
Grant date	Jan 15, 2019
Priority date	—
Expiry date	Feb 2, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies and compositions capable of neutralizing oncostatin M biological functions are useful in treating diseases and disorders associated with oncostatin M, such as osteoarthritis and idiopathic pulmonary fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.